(NasdaqGM:PRCT), SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics(R) Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2025. Recent Highlights Total revenue of $83.3 million for the third quarter […]

(NASDAQ:CPRX), CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it has been named as one of the BioSpace 2026 Best Places to Work

Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors GlobeNewswire November 04, 2025 DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf

Key Tronic Corporation Announces Results for The First Quarter of Fiscal Year 2026 GlobeNewswire November 04, 2025 Sequential Quarterly Increase in Gross Margins; Continued Program Wins; Positive Cash Flow from Operations SPOKANE VALLEY, Wash., Nov. 04, 2025 (GLOBE NEWSWIRE) — Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance GlobeNewswire November 04, 2025 SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics(R) Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work GlobeNewswire November 04, 2025 CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18 at 10:00 a.m. ET. https://mma.prnewswire.com/media/2460831/Grail_Logo.jpg Live and replay webcasts may be accessed in the investor relations section

Acquisition brings next-generation, cloud-native 911 technology into the Axon ecosystem, uniting connected devices, real-time communications, and digital evidence from call to courtroom. Axon (Nasdaq: AXON), the global public safety technology leader, today announced it has entered into a definitive agreement to acquire Carbyne, an innovative emergency communications and response platform serving hundreds of agencies protecting

— Third quarter 2025 total revenue of approximately $69.5 million, including record net product sales of $64.1 million and contract revenues from collaborations of $5.4 million — Generated $27.9 million of net income in the third quarter of 2025 — Completed enrollment in the dose escalation phase and enrolled the first patient in the dose

NASHVILLE, TN / ACCESS Newswire / November 4, 2025 / First Acceptance Corporation (OTCQX:FACO) today reported its financial results for the quarter ended September 30, 2025. A quarterly report can be found at www.otcmarkets.com/stock/FACO/disclosure. Revenues for the three months ended September 30, 2025 increased 9% to $140.7 million from $129.3 million in the same period